These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 17702040

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Recombinant human erythropoietin: effects on frataxin expression in vitro.
    Sturm B, Stupphann D, Kaun C, Boesch S, Schranzhofer M, Wojta J, Goldenberg H, Scheiber-Mojdehkar B.
    Eur J Clin Invest; 2005 Nov; 35(11):711-7. PubMed ID: 16269021
    [Abstract] [Full Text] [Related]

  • 3. Carbamylated erythropoietin increases frataxin independent from the erythropoietin receptor.
    Sturm B, Helminger M, Steinkellner H, Heidari MM, Goldenberg H, Scheiber-Mojdehkar B.
    Eur J Clin Invest; 2010 Jun; 40(6):561-5. PubMed ID: 20456483
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trial.
    Mariotti C, Fancellu R, Caldarazzo S, Nanetti L, Di Bella D, Plumari M, Lauria G, Cappellini MD, Duca L, Solari A, Taroni F.
    Mov Disord; 2012 Mar; 27(3):446-9. PubMed ID: 22411849
    [Abstract] [Full Text] [Related]

  • 7. Correlation of frataxin content in blood and skeletal muscle endorses frataxin as a biomarker in Friedreich ataxia.
    Nachbauer W, Wanschitz J, Steinkellner H, Eigentler A, Sturm B, Hufler K, Scheiber-Mojdehkar B, Poewe W, Reindl M, Boesch S.
    Mov Disord; 2011 Aug 15; 26(10):1935-8. PubMed ID: 21692115
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. GIFT-1, a phase IIa clinical trial to test the safety and efficacy of IFNγ administration in FRDA patients.
    Marcotulli C, Fortuni S, Arcuri G, Tomassini B, Leonardi L, Pierelli F, Testi R, Casali C.
    Neurol Sci; 2016 Mar 15; 37(3):361-4. PubMed ID: 26621361
    [Abstract] [Full Text] [Related]

  • 11. Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia.
    Auchère F, Santos R, Planamente S, Lesuisse E, Camadro JM.
    Hum Mol Genet; 2008 Sep 15; 17(18):2790-802. PubMed ID: 18562474
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of erythropoietin on frataxin levels and mitochondrial function in Friedreich ataxia--a dose-response trial.
    Nachbauer W, Hering S, Seifert M, Steinkellner H, Sturm B, Scheiber-Mojdehkar B, Reindl M, Strasak A, Poewe W, Weiss G, Boesch S.
    Cerebellum; 2011 Dec 15; 10(4):763-9. PubMed ID: 21597884
    [Abstract] [Full Text] [Related]

  • 14. Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study.
    Libri V, Yandim C, Athanasopoulos S, Loyse N, Natisvili T, Law PP, Chan PK, Mohammad T, Mauri M, Tam KT, Leiper J, Piper S, Ramesh A, Parkinson MH, Huson L, Giunti P, Festenstein R.
    Lancet; 2014 Aug 09; 384(9942):504-13. PubMed ID: 24794816
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Open-label pilot study of interferon gamma-1b in Friedreich ataxia.
    Seyer L, Greeley N, Foerster D, Strawser C, Gelbard S, Dong Y, Schadt K, Cotticelli MG, Brocht A, Farmer J, Wilson RB, Lynch DR.
    Acta Neurol Scand; 2015 Jul 09; 132(1):7-15. PubMed ID: 25335475
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Friedreich's ataxia and scoliosis: the experience at two institutions.
    Milbrandt TA, Kunes JR, Karol LA.
    J Pediatr Orthop; 2008 Mar 09; 28(2):234-8. PubMed ID: 18388721
    [Abstract] [Full Text] [Related]

  • 19. Co-enzyme Q10 and idebenone use in Friedreich's ataxia.
    Parkinson MH, Schulz JB, Giunti P.
    J Neurochem; 2013 Aug 09; 126 Suppl 1():125-41. PubMed ID: 23859348
    [Abstract] [Full Text] [Related]

  • 20. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up.
    Hart PE, Lodi R, Rajagopalan B, Bradley JL, Crilley JG, Turner C, Blamire AM, Manners D, Styles P, Schapira AH, Cooper JM.
    Arch Neurol; 2005 Apr 09; 62(4):621-6. PubMed ID: 15824263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.